The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications
Abstract
The use of nitric oxide (NO) is emerging as a promising, novel approach for the treatment of antibiotic resistant bacteria and biofilm infections. Depending on the concentration, NO can induce biofilm dispersal, increase bacteria susceptibility to antibiotic treatment, and induce cell damage or cell death via the formation of reactive oxygen or reactive nitrogen species. The use of NO is, however, limited by its reactivity, which can affect NO delivery to its target site and result in off-target effects. To overcome these issues, and enable spatial or temporal control over NO release, various strategies for the design of NO-releasing materials, including the incorporation of photo-activable, charge-switchable, or bacteria-targeting groups, have been developed. Other strategies have focused on increased NO storage and delivery by encapsulation or conjugation of NO donors within a single polymeric framework. This review compiles recent developments in NO drugs and NO-releasing materials designed for applications in antimicrobial or anti-biofilm treatment and discusses limitations and variability in biological responses in response to the use of NO for bacterial eradiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically, NO-triggered dispersal remains the best validated PDE activation approach. It transiently lowers c-di-GMP and enhances antibiotic activity, and is supported by controlled CF trials and progress in donor chemistry and delivery [134,278].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [278]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Wink, D. A., & Mitchell, J. B. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00092-6 · Cited by 1,606
Nathan, C., & Shiloh, M. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8841 · Cited by 1,469
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
PEPKEZABA, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)92033-x · Cited by 1,055
The Role of Nitric Oxide on Endothelial Function
Tousoulis, D., Kampoli, A.-M., Tentolouris Nikolaos Papageorgiou, C., & Stefanadis, C. (2012) · Current Vascular Pharmacology · doi:10.2174/157016112798829760 · Cited by 1,012
Hrabie, J. A., & Keefer, L. K. (2002) · Chemical Reviews · doi:10.1021/cr000028t · Cited by 466
Barraud, N., Storey, M. V., Moore, Z. P., Webb, J. S., Rice, S. A., & Kjelleberg, S. (2009) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2009.00098.x · Cited by 289
Self-citationWo, Y., Brisbois, E. J., Bartlett, R. H., & Meyerhoff, M. E. (2016) · Biomaterials Science · doi:10.1039/c6bm00271d · Cited by 251
Potential application of gaseous nitric oxide as a topical antimicrobial agent
Ghaffari, A., Miller, C. C., McMullin, B., & Ghahary, A. (2006) · Nitric Oxide · doi:10.1016/j.niox.2005.08.003 · Cited by 236 · cited 2×
“evaluated the use of gaseous NO against various pathogens and its effect on human dermal fibroblasts in culture [62].”
BackgroundNitric oxide–releasing macromolecular scaffolds for antibacterial applications
Yang, L., Feura, E. S., Ahonen, M. J. R., & Schoenfisch, M. H. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800155 · Cited by 218
Research works printed but not linked: 157
- Cox, 2013, Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions, Int. J. Med. Microbiol., 303, 287, 10.1016/j.ijmm.2013.02.009 · DOI · Paper page
- Abe, 2020, Biofilms: Hot spots of horizontal gene transfer (HGT) in aquatic environments, with a focus on a new HGT mechanism, FEMS Microbiol. Ecol., 96, fiaa031, 10.1093/femsec/fiaa031 · DOI · Paper page
- Davies, 2003, Understanding biofilm resistance to antibacterial agents, Nat. Rev. Drug Discov., 2, 114, 10.1038/nrd1008 · DOI · Paper page
- Srey, 2013, Biofilm formation in food industries: A food safety concern, Food Control, 31, 572, 10.1016/j.foodcont.2012.12.001 · DOI · Paper page
- 2018, Marine Biofilms: A Successful Microbial Strategy with Economic Implications, Front. Mar. Sci., 5, 126, 10.3389/fmars.2018.00126 · DOI · Paper page
- Barraud, 2006, Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa, J. Bacteriol., 188, 7344, 10.1128/JB.00779-06 · DOI · Paper page
- Beasley, 2013, Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development, J. Biol. Chem., 288, 6417, 10.1074/jbc.M112.448738 · DOI
- Levine, 2012, Characterization of the Role of Nitric Oxide and Its Clinical Applications, Cardiology, 122, 55, 10.1159/000338150 · DOI · Paper page
- Cai, 2021, NO donors and NO delivery methods for controlling biofilms in chronic lung infections, Appl. Microbiol. Biotechnol., 105, 3931, 10.1007/s00253-021-11274-2 · DOI · Paper page
- Grasemann, 2012, Nitric Oxide and L-Arginine Deficiency in Cystic Fibrosis, Curr. Pharm. Des., 18, 726, 10.2174/138161212799315911 · DOI
- Rouillard, 2020, Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models, J. Cyst. Fibros., 19, 1004, 10.1016/j.jcf.2020.03.004 · DOI
- Choi, 2020, Chitosan-based nitric oxide-releasing dressing for anti-biofilm and in vivo healing activities in MRSA biofilm-infected wounds, Int. J. Biol. Macromol., 142, 680, 10.1016/j.ijbiomac.2019.10.009 · DOI
- Eiserich, 1998, Pathophysiology of nitric oxide and related species: Free radical reactions and modification of biomolecules, Mol. Asp. Med., 19, 221, 10.1016/S0098-2997(99)00002-3 · DOI · Paper page
- Misra, 1991, DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its Progenitors, Science, 254, 1001, 10.1126/science.1948068 · DOI · Paper page
- Seabra, A.B. (2017). Chapter 7-Nitric Oxide Donors as Antimicrobial Agents. Nitric Oxide Donors, Academic Press.
- Ridnour, 2004, The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations, Biol. Chem., 385, 1, 10.1515/BC.2004.001 · DOI · Paper page
- Li, 2018, Chitosan-graft-PAMAM loading nitric oxide for efficient antibacterial application, Chem. Eng. J., 347, 923, 10.1016/j.cej.2018.04.159 · DOI
- Shen, 2019, Visible-Light-Triggered Self-Reporting Release of Nitric Oxide (NO) for Bacterial Biofilm Dispersal, Macromolecules, 52, 7668, 10.1021/acs.macromol.9b01252 · DOI
- Hou, 2020, Precisely Structured Nitric-Oxide-Releasing Copolymer Brush Defeats Broad-Spectrum Catheter-Associated Biofilm Infections In Vivo, Acs Cent. Sci., 6, 2031, 10.1021/acscentsci.0c00755 · DOI
- Yepuri, 2013, Synthesis of cephalosporin-3 ‘-diazeniumdiolates: Biofilm dispersing NO-donor prodrugs activated by beta-lactamase, Chem. Commun., 49, 4791, 10.1039/c3cc40869h · DOI
- Fei, 2020, Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections, J. Med. Chem., 63, 9127, 10.1021/acs.jmedchem.9b01832 · DOI
- Crane, 2010, Bacterial nitric oxide synthases, Annu. Rev. Biochem., 79, 445, 10.1146/annurev-biochem-062608-103436 · DOI · Paper page
- Sudhamsu, 2009, Bacterial nitric oxide synthases: What are they good for?, Trends Microbiol., 17, 212, 10.1016/j.tim.2009.02.003 · DOI · Paper page
- Poole, 2018, Chapter Five-Emerging Roles of Nitric Oxide Synthase in Bacterial Physiology, Advances in Microbial Physiology, Volume 72, 147, 10.1016/bs.ampbs.2018.01.006 · DOI
- Mihu, 2017, Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model, Antimicrob. Agents Chemother., 61, e02020-16, 10.1128/AAC.02020-16 · DOI
- Howlin, 2017, Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis, Mol. Ther., 25, 2104, 10.1016/j.ymthe.2017.06.021 · DOI · Paper page
- Arora, 2015, Nitric Oxide Regulation of Bacterial Biofilms, Biochemistry, 54, 3717, 10.1021/bi501476n · DOI · Paper page
- Deja, 2003, Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis, Am. J. Respir. Crit. Care Med., 168, 281, 10.1164/rccm.200207-640OC · DOI
- Hausladen, 1996, Nitrosative Stress: Activation of the Transcription Factor OxyR, Cell, 86, 719, 10.1016/S0092-8674(00)80147-6 · DOI · Paper page
- Vallance, 1998, Nitric oxide as an antimicrobial agent: Does NO always mean NO?, Gut, 42, 313, 10.1136/gut.42.3.313 · DOI
- Kuang, 2021, Inactivation of Nitrite-Dependent Nitric Oxide Biosynthesis Is Responsible for Overlapped Antibiotic Resistance between Naturally and Artificially Evolved Pseudomonas aeruginosa, mSystems, 6, e00732-21, 10.1128/mSystems.00732-21 · DOI
- Ehrt, 2009, Mycobacterial survival strategies in the phagosome: Defence against host stresses, Cell. Microbiol., 11, 1170, 10.1111/j.1462-5822.2009.01335.x · DOI · Paper page
- Kerr, 2004, Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae, Microb. Pathog., 36, 303, 10.1016/j.micpath.2004.02.001 · DOI
- Yang, 2020, Antibacterial action of nitric oxide-releasing hyperbranched polymers against ex vivo dental biofilms, Dent. Mater., 36, 635, 10.1016/j.dental.2020.03.012 · DOI
- Barnes, 2013, Optimal dosing regimen of nitric oxide donor compounds for the reduction of Pseudomonas aeruginosa biofilm and isolates from wastewater membranes, Biofouling, 29, 203, 10.1080/08927014.2012.760069 · DOI
- Zhu, 2018, Nitric Oxide-Mediated Induction of Dispersal in Pseudomonas aeruginosa Biofilms Is Inhibited by Flavohemoglobin Production and Is Enhanced by Imidazole, Antimicrob. Agents Chemother., 62, e01832-17, 10.1128/AAC.01832-17 · DOI · Paper page
- Hasan, 2018, Mechanistic studies of the antibiofilm activity and synergy with antibiotics of isosorbide mononitrate, Eur. J. Pharm. Sci., 115, 50, 10.1016/j.ejps.2018.01.003 · DOI
- Ren, 2016, Efficient Eradication of Mature Pseudomonas aeruginosa Biofilm via Controlled Delivery of Nitric Oxide Combined with Antimicrobial Peptide and Antibiotics, Front. Microbiol., 7, 1260, 10.3389/fmicb.2016.01260 · DOI
- Zemke, 2020, Antimicrobial Synergism Toward Pseudomonas aeruginosaby Gallium(III) and Inorganic Nitrite, Front. Microbiol., 11, 2113, 10.3389/fmicb.2020.02113 · DOI
- Rouillard, 2021, Exogenous Nitric Oxide Improves Antibiotic Susceptibility in Resistant Bacteria, ACS Infect. Dis., 7, 23, 10.1021/acsinfecdis.0c00337 · DOI
- Ouadrhiri, 1999, Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon, Antimicrob. Agents Chemother., 43, 1242, 10.1128/AAC.43.5.1242 · DOI
- Huang, 2021, Nitric oxide pretreatment enhances ofloxacin susceptibility of biofilm concomitant with exopolysaccharide depletion, Colloid Interface Sci. Commun., 41, 100371, 10.1016/j.colcom.2021.100371 · DOI
- Allan, 2016, Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance, Antimicrob. Agents Chemother., 60, 2456, 10.1128/AAC.02432-15 · DOI
- Nandanwar, 2021, Growth medium and nitric oxide alter Mycobacterium abscessus morphotype and virulence, Microbiol. Res., 253, 126887, 10.1016/j.micres.2021.126887 · doi:10.1016/j.micres.2021.126887
- Krause, 2016, Aminoglycosides: An Overview, Cold Spring Harb. Perspect. Med., 6, a027029, 10.1101/cshperspect.a027029 · DOI · Paper page
- McCollister, 2011, Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake, Antimicrob. Agents Chemother., 55, 2189, 10.1128/AAC.01203-10 · DOI
- Nguyen, 2016, Co-delivery of nitric oxide and antibiotic using polymeric nanoparticles, Chem. Sci., 7, 1016, 10.1039/C5SC02769A · DOI · Paper page
- Duan, 2021, Photoresponsive Vesicles Enabling Sequential Release of Nitric Oxide (NO) and Gentamicin for Efficient Biofilm Eradication, Macromol. Rapid Commun., 42, e2000759, 10.1002/marc.202000759 · DOI
- Wiegand, 2021, Antimicrobial effects of nitric oxide in murine models of Klebsiella pneumonia, Redox. Biol., 39, 101826, 10.1016/j.redox.2020.101826 · DOI
- Michaelsen, 2020, Gaseous Nitric Oxide (gNO) as a Potential Antimicrobial Therapy during Ex Vivo Lung Perfusion: An Efficacy and Safety Study, J. Heart Lung Transplant., 39, S46, 10.1016/j.healun.2020.01.1217 · doi:10.1016/j.healun.2020.01.1217
- Bogdanovski, 2020, Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease, Access Microbiol., 2, acmi000154, 10.1099/acmi.0.000154 · DOI
- Bentur, 2020, Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection, J. Cyst. Fibros., 19, 225, 10.1016/j.jcf.2019.05.002 · DOI
- Bartley, 2020, High-Dose Inhaled Nitric Oxide as Adjunct Therapy in Cystic Fibrosis Targeting Burkholderia multivorans, Case Rep. Pediatri., 2020, 1536714
- Zhao, 2021, Light-Triggered Nitric Oxide Release by a Photosensitizer to Combat Bacterial Biofilm Infections, Chem. A Eur. J., 27, 5453, 10.1002/chem.202004698 · DOI
- Boce, 2019, Effect of trans(NO, OH)- RuFT(CI)(OH)NO (PF6) ruthenium nitrosyl complex on methicillin-resistant Staphylococcus epidermidis, Sci. Rep., 9, 4867, 10.1038/s41598-019-41222-0 · DOI
- Cariello, 2012, Bactericidal effect of S-nitrosothiols against clinical isolates from keratitis, Clin. Ophthalmol., 6, 1907, 10.2147/OPTH.S34830 · DOI
- Barnes, 2015, Nitric oxide treatment for the control of reverse osmosis membrane biofouling, Appl. Environ. Microbiol., 81, 2515, 10.1128/AEM.03404-14 · DOI
- Marvasi, 2014, Systematic analysis of the ability of Nitric Oxide donors to dislodge biofilms formed by Salmonella enterica and Escherichia coli O157:H7, AMB Express, 4, 42, 10.1186/s13568-014-0042-y · DOI
- Poh, 2017, Furoxan Nitric Oxide Donors Disperse Pseudomonas aeruginosa Biofilms, Accelerate Growth, and Repress Pyoverdine Production, ACS Chem. Biol., 12, 2097, 10.1021/acschembio.7b00256 · DOI
- Orlandi, 2018, Anti-Pseudomonas activity of 3-nitro-4-phenylfuroxan, Microbiology, 164, 1557, 10.1099/mic.0.000730 · DOI
- Allan, 2017, Cephalosporin-NO-donor prodrug PYRRO-C3D shows beta-lactam-mediated activity against Streptococcus pneumoniae biofilms, Nitric Oxide Biol. Chem., 65, 43, 10.1016/j.niox.2017.02.006 · DOI
- Barraud, 2012, Cephalosporin-3 ‘-diazeniumdiolates: Targeted NO-Donor Prodrugs for Dispersing Bacterial Biofilms, Angew. Chem. Int. Ed., 51, 9057, 10.1002/anie.201202414 · DOI · Paper page
- Collins, 2017, Cephalosporin-3 ‘-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms, Antimicrob. Agents Chemother., 61, e02086-16, 10.1128/AAC.02086-16 · DOI
- Rineh, 2020, Discovery of Cephalosporin-3 ‘-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against Pseudomonas aeruginosa Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection Model, Acs Infect. Dis., 6, 1460, 10.1021/acsinfecdis.0c00070 · DOI
- Soren, 2020, Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa, J. Antimicrob. Chemother., 75, 117, 10.1093/jac/dkz378 · DOI
- Kutty, 2013, Design, Synthesis, and Evaluation of Firnbrolide-Nitric Oxide Donor Hybrids as Antimicrobial Agents, J. Med. Chem., 56, 9517, 10.1021/jm400951f · DOI
- Frostell, 1991, Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction, Circulation, 83, 2038, 10.1161/01.CIR.83.6.2038 · DOI · Paper page
- Ghaffari, 2007, Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections, Wound Repair Regen, 15, 368, 10.1111/j.1524-475X.2007.00239.x · DOI
- Sulemankhil, 2012, Prevention and Treatment of Virulent Bacterial Biofilms with an Enzymatic Nitric Oxide-Releasing Dressing, Antimicrob. Agents Chemother., 56, 6095, 10.1128/AAC.01173-12 · DOI
- Waite, 2018, Activity of a nitric oxide-generating wound treatment system against wound pathogen biofilms, Int. J. Antimicrob. Agents, 52, 338, 10.1016/j.ijantimicag.2018.04.009 · DOI
- Hall, 2020, Mode of Nitric Oxide Delivery Affects Antibacterial Action, ACS Biomater. Sci. Eng., 6, 433, 10.1021/acsbiomaterials.9b01384 · DOI
- Chau, 2019, High Efficacy of High-dose Nitric Oxide and its Synergistic Effect with Antibiotics against Mycobacterium Abscessus, Eur. Respir. J., 54, OA4950
- Salguero, 2002, Inhaled nitric oxide and methemoglobin in full-term infants with persistent pulmonary hypertension of the newborn, Pulm. Pharm. Ther., 15, 1, 10.1006/pupt.2001.0311 · doi:10.1006/pupt.2001.0311
- Young, 1994, Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide, Intensive Care Med., 20, 581, 10.1007/BF01705726 · DOI
- Miller, 2009, Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure, Nitric Oxide, 20, 16, 10.1016/j.niox.2008.08.002 · DOI
- Schulz, 1982, Cyanide toxicity of sodium nitroprusside in therapeutic use with and without sodium thiosulphate, Klin. Wochenschr., 60, 1393, 10.1007/BF01716244 · DOI
- Seabra, 2004, Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin, Br. J. Derm., 151, 977, 10.1111/j.1365-2133.2004.06213.x · DOI
- Pankotai, 2011, Current developments in the therapeutic potential of S-nitrosoglutathione, an endogenous NO-donor molecule, Curr. Pharm. Biotechnol., 12, 1368, 10.2174/138920111798280983 · DOI
- 2016, S-Nitrosothiols as Platforms for Topical Nitric Oxide Delivery, Basic Clin. Pharmacol. Toxicol., 119, 49, 10.1111/bcpt.12588 · DOI
- Lu, 2015, S-Nitrosothiol-modified nitric oxide-releasing chitosan oligosaccharides as antibacterial agents, Acta Biomater., 12, 62, 10.1016/j.actbio.2014.10.028 · DOI
- Denadai, 2019, Long-term decomposition of aqueous S-nitrosoglutathione and S-nitroso-N-acetylcysteine: Influence of concentration, temperature, pH and light, Nitric Oxide, 84, 30, 10.1016/j.niox.2019.01.002 · DOI
- Zhelyaskov, 1998, Control of NO concentration in solutions of nitrosothiol compounds by light, Photochem. Photobiol., 67, 282, 10.1111/j.1751-1097.1998.tb05200.x · DOI
- Kumari, 2014, The design of nitric oxide donor drugs: S-nitrosothiol tDodSNO is a superior photoactivated donor in comparison to GSNO and SNAP, Eur. J. Pharmacol., 737, 168, 10.1016/j.ejphar.2014.05.012 · DOI
- Riccio, 2012, Photoinitiated nitric oxide-releasing tertiary S-nitrosothiol-modified xerogels, ACS Appl. Mater. Interfaces, 4, 796, 10.1021/am201443r · DOI
- Keefer, 2011, Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances, ACS Chem. Biol., 6, 1147, 10.1021/cb200274r · DOI · Paper page
- Ahonen, 2019, Antibiofilm Efficacy of Nitric Oxide-Releasing Alginates against Cystic Fibrosis Bacterial Pathogens, ACS Infect. Dis., 5, 1327, 10.1021/acsinfecdis.9b00016 · DOI
- Backlund, 2016, Anti-biofilm action of nitric oxide-releasing alkyl-modified poly(amidoamine) dendrimers against Streptococcus mutans, Acta Biomater., 29, 198, 10.1016/j.actbio.2015.10.021 · DOI
- Worley, 2015, Anti-Biofilm Efficacy of Dual-Action Nitric Oxide-Releasing Alkyl Chain Modified Poly(amidoamine) Dendrimers, Mol. Pharm., 12, 1573, 10.1021/acs.molpharmaceut.5b00006 · DOI
- Worley, 2014, Nitric Oxide-Releasing Quaternary Ammonium-Modified Poly(amidoamine) Dendrimers as Dual Action Antibacterial Agents, Bioconjugate Chem., 25, 918, 10.1021/bc5000719 · DOI
- Lu, 2011, Structurally Diverse Nitric Oxide-Releasing Poly(propylene Imine) Dendrimers, Chem. Mater., 23, 4227, 10.1021/cm201628z · DOI
- Hetrick, 2008, Bactericidal efficacy of nitric oxide-releasing silica nanoparticles, ACS Nano, 2, 235, 10.1021/nn700191f · DOI · Paper page
- Adnan, 2018, Exploiting the Versatility of Polydopamine-Coated Nanoparticles to Deliver Nitric Oxide and Combat Bacterial Biofilm, Macromol. Rapid Commun., 39, e1800159, 10.1002/marc.201800159 · DOI
- Zhu, 2019, Nitric Oxide and Iron Signaling Cues Have Opposing Effects on Biofilm Development in Pseudomonas aeruginosa, Appl. Environ. Microbiol., 85, e02175-18, 10.1128/AEM.02175-18 · DOI
- Cai, 2020, Optimization of nitric oxide donors for investigating biofilm dispersal response in Pseudomonas aeruginosaclinical isolates, Appl. Microbiol. Biotechnol., 104, 8859, 10.1007/s00253-020-10859-7 · DOI
- Gasco, 2004, NO donors: Focus on furoxan derivatives, Pure Appl. Chem., 76, 973, 10.1351/pac200476050973 · doi:10.1351/pac200476050973
- Sorba, 1997, Water soluble furoxan derivatives as NO prodrugs, J. Med. Chem., 40, 463, 10.1021/jm960379t · DOI
- Guo, 2017, Ruthenium nitrosyl functionalized graphene quantum dots as an efficient nanoplatform for NIR-light-controlled and mitochondria-targeted delivery of nitric oxide combined with photothermal therapy, Chem. Commun., 53, 3253, 10.1039/C7CC00670E · DOI
- Rose, 2008, Photoactive ruthenium nitrosyls: Effects of light and potential application as NO donors, Coord. Chem. Rev., 252, 2093, 10.1016/j.ccr.2007.11.011 · DOI · Paper page
- Taunk, 2018, Dual-Action Biomaterial Surfaces with Quorum Sensing Inhibitor and Nitric Oxide To Reduce Bacterial Colonization, ACS Biomater. Sci. Eng., 4, 4174, 10.1021/acsbiomaterials.8b00816 · DOI
- Lu, 2014, Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents, Biomaterials, 35, 1716, 10.1016/j.biomaterials.2013.11.015 · DOI · Paper page
- Reighard, 2015, Disruption and eradication of P. aeruginosa biofilms using nitric oxide-releasing chitosan oligosaccharides, Biofouling, 31, 775, 10.1080/08927014.2015.1107548 · DOI · Paper page
- Tang, 2016, Managing bacterial biofilms with chitosan-based polymeric nitric oxides: Inactivation of biofilm bacteria and synergistic effects with antibiotics, J. Bioact. Compat. Polym., 31, 393, 10.1177/0883911515623798 · DOI
- Hasan, 2017, Controlled and Localized Nitric Oxide Precursor Delivery From Chitosan Gels to Staphylococcus aureus Biofilms, J. Pharm. Sci., 106, 3556, 10.1016/j.xphs.2017.08.006 · DOI
- Sundaram, 2016, Antimicrobial and Physicochemical Characterization of Biodegradable, Nitric Oxide-Releasing Nanocellulose–Chitosan Packaging Membranes, J. Agric. Food Chem., 64, 5260, 10.1021/acs.jafc.6b01936 · DOI
- Liu, 2020, Chitosan derivatives co-delivering nitric oxide and methicillin for the effective therapy to the methicillin-resistant S. aureus infection, Carbohydr. Polym., 234, 115928, 10.1016/j.carbpol.2020.115928 · DOI
- Ahonen, 2018, Nitric Oxide-Releasing Alginates, Biomacromolecules, 19, 1189, 10.1021/acs.biomac.8b00063 · DOI
- Rouillard, 2020, Pseudomonas aeruginosa Biofilm Eradication via Nitric Oxide-Releasing Cyclodextrins, ACS Infect. Dis., 6, 1940, 10.1021/acsinfecdis.0c00246 · DOI
- Jin, 2018, Nitric Oxide-Releasing Cyclodextrins, J. Am. Chem Soc., 140, 14178, 10.1021/jacs.8b07661 · DOI
- Hetrick, 2009, Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles, Biomaterials, 30, 2782, 10.1016/j.biomaterials.2009.01.052 · DOI · Paper page
- Carpenter, 2011, Influence of Scaffold Size on Bactericidal Activity of Nitric Oxide-Releasing Silica Nanoparticles, ACS Nano, 5, 7235, 10.1021/nn202054f · DOI
- Slomberg, 2013, Role of Size and Shape on Biofilm Eradication for Nitric Oxide-Releasing Silica Nanoparticles, ACS Appl. Mater. Interfaces, 5, 9322, 10.1021/am402618w · DOI · Paper page
- Backlund, 2015, Kinetic-dependent Killing of Oral Pathogens with Nitric Oxide, J. Dent. Res., 94, 1092, 10.1177/0022034515589314 · DOI
- Martinez, 2009, Antimicrobial and Healing Efficacy of Sustained Release Nitric Oxide Nanoparticles Against Staphylococcus Aureus Skin Infection, J. Investig. Dermatol., 129, 2463, 10.1038/jid.2009.95 · DOI · Paper page
- Sadrearhami, 2017, Biofilm dispersal using nitric oxide loaded nanoparticles fabricated by photo-PISA: Influence of morphology, Chem. Commun., 53, 12894, 10.1039/C7CC07293G · DOI
- Hasan, 2017, Biodegradable nitric oxide precursor-loaded micro- and nanoparticles for the treatment of Staphylococcus aureus biofilms, J. Mater. Chem. B, 5, 1005, 10.1039/C6TB03290G · DOI
- Hasan, 2019, PEI/NONOates-doped PLGA nanoparticles for eradicating methicillin-resistant Staphylococcus aureus biofilm in diabetic wounds via binding to the biofilm matrix, Mater. Sci. Eng. C Mater. Biol. Appl., 103, 109741, 10.1016/j.msec.2019.109741 · DOI
- Zhang, 2020, Effects of isosorbide mononitrate loaded nanoparticles conjugated with anti-Staphylococcus aureus α-toxin on Staphylococcus aureus biofilms, Exp. Ther. Med., 19, 1267
- Liu, 2021, Surface charge switchable nanoparticles capable of controlled nitric oxide release for the treatment of acidity-associated bacterial infections, Polym. Chem., 12, 1023, 10.1039/D0PY01460E · doi:10.1039/d0py01460e
- Hu, 2020, Surface Charge Switchable Supramolecular Nanocarriers for Nitric Oxide Synergistic Photodynamic Eradication of Biofilms, ACS Nano, 14, 347, 10.1021/acsnano.9b05493 · DOI · Paper page
- Yuan, 2020, Near-Infrared Light-Triggered Nitric-Oxide-Enhanced Photodynamic Therapy and Low-Temperature Photothermal Therapy for Biofilm Elimination, ACS Nano, 14, 3546, 10.1021/acsnano.9b09871 · DOI · Paper page
- Sun, 2021, Near-infrared light triggered photodynamic and nitric oxide synergistic antibacterial nanocomposite membrane, Chem. Eng. J., 417, 128049, 10.1016/j.cej.2020.128049 · DOI · Paper page
- Zhu, 2021, L-Arg-Rich Amphiphilic Dendritic Peptide as a Versatile NO Donor for NO/Photodynamic Synergistic Treatment of Bacterial Infections and Promoting Wound Healing, Small, 17, 2101495, 10.1002/smll.202101495 · DOI
- Lu, 2013, Nitric Oxide-Releasing Amphiphilic Poly(amidoamine) (PAMAM) Dendrimers as Antibacterial Agents, Biomacromolecules, 14, 3589, 10.1021/bm400961r · DOI
- Backlund, 2014, Antibacterial Efficacy of Exogenous Nitric Oxide on Periodontal Pathogens, J. Dent. Res., 93, 1089, 10.1177/0022034514529974 · DOI
- Yang, 2018, Antibacterial Activity of Nitric Oxide-Releasing Hyperbranched Polyamidoamines, Bioconjug. Chem., 29, 35, 10.1021/acs.bioconjchem.7b00537 · DOI
- Storm, 2014, Superhydrophobic nitric oxide-releasing xerogels, Acta Biomater., 10, 3442, 10.1016/j.actbio.2014.04.029 · DOI
- Craven, 2016, Nitric oxide-releasing polyacrylonitrile disperses biofilms formed by wound-relevant pathogenic bacteria, J. Appl. Microbiol., 120, 1085, 10.1111/jam.13059 · DOI
- Fleming, G., Aveyard, J., Fothergill, J.L., McBride, F., Raval, R., and D’Sa, R.A. (2017). Nitric Oxide Releasing Polymeric Coatings for the Prevention of Biofilm Formation. Polymers, 9. · DOI
- Wo, 2017, Study of crystal formation and nitric oxide (NO) release mechanism from S-nitroso-N-acetylpenicillamine (SNAP)-doped CarboSil polymer composites for potential antimicrobial applications, Compos. Part B Eng., 121, 23, 10.1016/j.compositesb.2017.03.027 · DOI
- Singha, 2017, Enhanced antibacterial efficacy of nitric oxide releasing thermoplastic polyurethanes with antifouling hydrophilic topcoats, Biomater. Sci., 5, 1246, 10.1039/C6BM00948D · DOI
- Mondal, 2021, Highly hydrophobic polytetrafluoroethylene particle immobilization via polydopamine anchor layer on nitric oxide releasing polymer for biomedical applications, J. Colloid Interface Sci., 585, 716, 10.1016/j.jcis.2020.10.051 · DOI
- Homeyer, 2019, Liquid-Infused Nitric-Oxide-Releasing Silicone Foley Urinary Catheters for Prevention of Catheter-Associated Urinary Tract Infections, Acs Biomater. Sci. Eng., 5, 2021, 10.1021/acsbiomaterials.8b01320 · DOI
- Sadrearhami, 2019, Antibiofilm Nitric Oxide-Releasing Polydopamine Coatings, ACS Appl. Mater. Interfaces, 11, 7320, 10.1021/acsami.8b16853 · DOI
- Li, 2020, Nitric Oxide Releasing Titanium Surfaces for Antimicrobial Bone-Integrating Orthopedic Implants, ACS Appl. Mater. Interfaces, 12, 22433, 10.1021/acsami.0c00871 · DOI
- Sadrearhami, 2019, S-Nitrosothiol Plasma-Modified Surfaces for the Prevention of Bacterial Biofilm Formation, Acs Biomater. Sci. Eng., 5, 5881, 10.1021/acsbiomaterials.9b01063 · DOI
- Ke, C.-L., Deng, F.-S., Chuang, C.-Y., and Lin, C.-H. (2021). Antimicrobial Actions and Applications of Chitosan. Polymers, 13. · DOI · Paper page
- Cohen, E., and Merzendorfer, H. (2019). Alginate: Pharmaceutical and Medical Applications. Extracellular Sugar-Based Biopolymers Matrices, Springer International Publishing. · doi:10.1007/978-3-030-12919-4
- Urzedo, 2020, Cytotoxicity and Antibacterial Activity of Alginate Hydrogel Containing Nitric Oxide Donor and Silver Nanoparticles for Topical Applications, ACS Biomater. Sci. Eng., 6, 2117, 10.1021/acsbiomaterials.9b01685 · DOI
- Reighard, 2017, Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity, ACS Biomater. Sci. Eng., 3, 1017, 10.1021/acsbiomaterials.7b00039 · DOI
- Ahmadi, 2016, Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model, Antimicrob. Agents Chemother., 60, 2185, 10.1128/AAC.02659-15 · DOI · Paper page
- Rong, F., Tang, Y.Z., Wang, T.J., Feng, T., Song, J., Li, P., and Huang, W. (2019). Nitric Oxide-Releasing Polymeric Materials for Antimicrobial Applications: A Review. Antioxidants, 8. · DOI · Paper page
- Friedman, 2011, Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione, Nitric Oxide, 25, 381, 10.1016/j.niox.2011.09.001 · DOI
- Li, 2019, Synergistic in vitro effects of indocyanine green and ethylenediamine tetraacetate-mediated antimicrobial photodynamic therapy combined with antibiotics for resistant bacterial biofilms in diabetic foot infection, Photodiagnosis Photodyn. Ther., 25, 300, 10.1016/j.pdpdt.2019.01.010 · DOI
- Biel, 2011, Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms, Int. Forum Allergy Rhinol., 1, 329, 10.1002/alr.20089 · DOI
- Biel, 2013, Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model, Int. Forum Allergy Rhinol., 3, 468, 10.1002/alr.21134 · doi:10.1002/alr.21134
- Caminade, 2015, Dendrimers and hyperbranched polymers, Chem. Soc. Rev., 44, 3870, 10.1039/C5CS90049B · DOI · Paper page
- Liu, 2021, Beta-Cyclodextrin-graft-poly(amidoamine) dendrons as the nitric oxide deliver system for the chronic rhinosinusitis therapy, Drug Deliv., 28, 306, 10.1080/10717544.2021.1876183 · DOI
- Yang, 2018, Nitric Oxide-Releasing Hyperbranched Polyaminoglycosides for Antibacterial Therapy, ACS Appl. Bio Mater., 1, 1066, 10.1021/acsabm.8b00304 · DOI
- Sun, 2012, Nitric oxide-releasing dendrimers as antibacterial agents, Biomacromolecules, 13, 3343, 10.1021/bm301109c · DOI
- Lopez, 2009, Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers, Mol. Biosyst., 5, 1148, 10.1039/b904746h · DOI
- Wang, 2010, Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers, Int. J. Pharm., 395, 298, 10.1016/j.ijpharm.2010.05.030 · DOI
- Devine, 2019, Versatile biomimetic medical device surface: Hydrophobin coated, nitric oxide-releasing polymer for antimicrobial and hemocompatible applications, Biomater. Sci., 7, 3438, 10.1039/C9BM00469F · DOI
- Clarke, 2005, Conformational Changes of Fibrinogen after Adsorption, J. Phys. Chem. B, 109, 22027, 10.1021/jp054456k · DOI
- Michl, 2015, Nitric oxide releasing plasma polymer coating with bacteriostatic properties and no cytotoxic side effects, Chem. Commun., 51, 7058, 10.1039/C5CC01722J · DOI
- Marxer, 2003, Preparation of nitric oxide (NO)-releasing sol-gels for biomaterial applications, Chem. Mater., 15, 4193, 10.1021/cm034347n · DOI
- Chen, 2010, Surface hydration: Principles and applications toward low-fouling/nonfouling biomaterials, Polymer, 51, 5283, 10.1016/j.polymer.2010.08.022 · DOI · Paper page
- Nablo, 2004, Poly(vinyl chloride)-Coated Sol−Gels for Studying the Effects of Nitric Oxide Release on Bacterial Adhesion, Biomacromolecules, 5, 2034, 10.1021/bm049727w · DOI
Cited by
Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
Andrabi, S. M., Sharma, N. S., Karan, A., Shahriar, S. M. S., Cordon, B., Ma, B., & Xie, J. (2023) · Advanced Science · doi:10.1002/advs.202303259 · Cited by 602
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Metadata
- Authors
- Poh, W. H., & Rice, S. A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2022-01-20
- Volume
- 27
- Issue
- 3
- Pages
- 674
- ISSN
- 1420-3049
- Cited by
- 114
- References
- 19
- Language
- en
- Funders
- Ministry of Education (MOE2019-T2-1-050)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications. https://app.cochat.ai/papers/10.3390/molecules27030674
- The paper
- Poh, W. H., & Rice, S. A. (2022). Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications. Molecules. https://doi.org/10.3390/molecules27030674
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.